We could demonstrate that treatment with 10–7 M Triptorelin led to an increased cell-ECM adhesion in mesenchymal transformed breast cancer cells and TNBC cells as it was detected by CTGF suppression as well. This evidence concerns the gene CCN2 and breast carcinoma.